http://www.sarepta.com
Sarepta Therapeutics, Inc. Company Intro
We are focused on the development of precision genetic medicines to treat rare neuromuscular and central nervous system diseases. Learn more about Sarepta.
Industry
Healthcare
Sarepta Therapeutics, Inc. Headquaters
215 First Street
Cambridge,02142
United States
Sarepta Therapeutics, Inc. Share price
22 Jan 2021 02:38 GMT
$99.03
2.27 (2.35 %)
Sarepta Therapeutics, Inc. Market cap
$7.648 B
WMC RANKING
2021
Sarepta Therapeutics, Inc. # 20
BiotechnologyLatest Sarepta Therapeutics, Inc. News
09 Jan 2021
Mastec Inc (MTZ) CFO George Pita Sold $2.4 million of Shares
A lottery ticket, however, costs only a buck or two, while getting a biotech company wrong can hurt a lot more than that. Case in point: Sarepta Therapeutics (SRPT) ...
09 Jan 2021
Merrill Lynch Stick to Their Buy Rating for Sarepta ...
Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the ...
09 Jan 2021
Marburgvirus Infection Market Report, History and Forecast ...
... Infection are:,Arno Therapeutics Inc,NanoViricides Inc,Emergent BioSolutions Inc ... Inc,Fab'entech SA,Profectus BioSciences Inc,Sarepta Therapeutics Inc ...
WMC Market Score
WMC Market to Revenue Score
Sarepta Therapeutics, Inc. Market Financials
Revenue, Expenses, Profit
| Company | Currency | Revenue | Expense | Profit | Market Cap | WMC Sector Score |
| Sarepta Therapeutics, Inc. | USD | $365,135 | $925,688 | $-620,267 | $76,480B | 20 |
| Regeneron Pharmaceuticals, Inc. | USD | $9,243,500 | $5,152,600 | $3,156,000 | $571,390B | 1 |
| Alexion Pharmaceuticals, Inc. | USD | $5,862,400 | $2,588,400 | $956,600 | $345,270B | 2 |
| Vertex Pharmaceuticals Incorporated | USD | $5,991,128 | $2,596,854 | $2,690,691 | $620,550B | 3 |
| ALK-Abello A/S | USD | $3,383,000 | $1,831,000 | $43,000 | $271,640B | 4 |
Market Analytics
Company Search vs Top 4 Industry Competitors
Total Sarepta Therapeutics, Inc. Social Followers vs Top 4 Industry Competitors
Sarepta Therapeutics, Inc. Post vs Top 4 Industry Competitors
Sarepta Therapeutics, Inc. Digital Footprint By Size vs Top 4 Industry Competitors
Sarepta Therapeutics, Inc. Digital Footprint By Change Rate vs Top 4 Industry Competitors
Sarepta Therapeutics, Inc. WMC Market Score Calculations
| Details | Revenue | Total Social Followers | Total Social Posts | Search Volume | Digital Footprint Size | Digital change (New Pages) | WMC Market Score |
| Sarepta Therapeutics, Inc. | 3.95 | 13.97 | 22.55 | 0 | 0 | 0 | 18.73 |
| Regeneron Pharmaceuticals, Inc. | 100 | 66.33 | 29.44 | 100 | 0 | 0 | 100 |
| Alexion Pharmaceuticals, Inc. | 63.42 | 16.28 | 100 | 60 | 0 | 0 | 90.10 |
| Vertex Pharmaceuticals Incorporated | 64.81 | 100 | 8.77 | 86 | 0 | 0 | 99.40 |
| ALK-Abello A/S | 36.60 | 0 | 0 | 0 | 0 | 0 | 0 |
Book a demo
Book a free one-on-one demo with one of our team and see exactly how the WMC business intelligence platform can help you protect and grow revenue.
* required fields
You'll learn how to:
- 1. Automatically monitor your entire digital landscape including competitors
- 2. View all new industry activity in real time
- 3. Monitor your position in your industry
- 4. Enrich your reports and strategy
- 5. Empower your teams with knowledge
